• Home
  • Investor Relations
  • Corporate Governance
  • SEC Filings
  • Newsroom
Celularity
  • Home
  • Investor Relations
  • Corporate Governance
  • SEC Filings
  • Newsroom
  • Home
  • Investor Relations
  • Corporate Governance
  • SEC Filings
  • Newsroom
All rights reserved
Celularity
MENU

Celularity Inc.

SEC Filings

Celularity_Nasdaq_CELU-copy-376x65

Nasdaq provides the company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia.

The SEC requires all publicly traded companies, foreign and domestic, to disclose financial conditions, operating results, management compensation, and other areas of their business on a regular basis. This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the SEC’s EDGAR database.

Email Alerts
RSS Feed - SEC Filings
RSS Feed - Press Releases
Print Page
Celularity_Nasdaq_CELU-1

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.

Company

  • About
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Tour Our Facility
  • Careers

Science

  • Pipeline
  • NK Cell Platform
  • T Cell Platform
  • Lifebank
  • Advanced Biomaterials
  • Manufacturing

Investors

  • Investor Relations
  • Partnerships
  • SEC Filings
  • Corporate Governance
  • Press Releases

Nasdaq:CELU

Nasdaq:CELU

Celularity Inc. © 2025. All rights reserved.     Privacy Policy     Terms & Conditions

Company
  • About
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Tour Our Facility
  • Careers
Science
  • Pipeline
  • NK Cell Platform
  • T Cell Platform
  • Lifebank
  • Advanced Biomaterials
  • Manufacturing
Investors
  • Investor Relations
  • Partnerships
  • SEC Filings
  • Corporate Governance
  • Press Releases

Celularity Inc. © 2024. All rights reserved.
Privacy Policy     Terms & Conditions

in
F.A.Q
Support Forum
Video Tutorials

Search panel can contain any widgets and shortcodes.

Call us: (908) 768 – 2170